We demonstrated CP, at dose of 15 mg kg-1, decreased weight and length and produced cleft palate (55.56%), exencephaly (27.77%), spina bifida (33.34%) and omphalocele (11.11%) among all fetuses. This evidence concerns the gene CP and cleft palate.